South Africa asks Serum Institute of India to take back one million vaccine doses - report


FILE PHOTO: A health official draws a dose of the AstraZeneca's COVID-19 vaccine manufactured by the Serum Institute of India, at Infectious Diseases Hospital in Colombo, Sri Lanka January 29, 2021. REUTERS/Dinuka Liyanawatte/File Photo

(Reuters) - South Africa has asked the Serum Institute of India to take back 1 million doses of COVID-19 vaccine that the company had sent in early February, The Economic Times reported on Tuesday.

Last week, South Africa's health minister said the government may sell doses of AstraZeneca's vaccine, after the country paused its rollout following a small clinical trial that showed it offered minimal protection against mild to moderate illness from the 501Y.V2 coronavirus variant dominant in the country.

(Reporting by Ann Maria Shibu and Shubham Kalia in Bengaluru; Editing by Kim Coghill)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
   

Next In World

Mexico to vaccinate migrants in Baja California under new border initiative
N.Korea's Kim tightens ruling party discipline, appoints new politburo members
Peru ex-military stir election tensions with appeal to Armed Forces to "remedy" poll
Canada vows to nearly double intake of 'protected persons' as refugee family backlog grows
Venezuela opposition committee to seek support in Washington, Brussels
Uganda imposes new anti-coronavirus measures to stem raging pandemic
Mexico City mayor to construction firms: Pay up for collapsed metro line
Businesses, U.S. legislators fume as Canada extends travel ban; Trudeau stands firm
Merkel and Macron urge EU coordination on reopening borders
Italy's Draghi urges no vaccine let up, signals AstraZeneca U-turn

Stories You'll Enjoy


Vouchers